| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/27/2009 | US20090217391 T1r3 a novel taste receptor |
| 08/27/2009 | US20090217390 Non-human animal sarcoma model |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215908 Toll like receptor (tlr) signaling antagonist |
| 08/27/2009 | US20090215875 Methods and kits for expanding hematopoietic stem cells |
| 08/27/2009 | US20090215872 Methods for Controlling Stem Cell Differentiation |
| 08/27/2009 | US20090215866 Akt ligands and polynucleotides encoding akt ligands |
| 08/27/2009 | US20090215863 Gene Silencing of Protease Activated Receptor 1(Par1) |
| 08/27/2009 | US20090215860 Compositions and methods for regulating gene transcription |
| 08/27/2009 | US20090215859 Compositions and methods for modulating dhr96 |
| 08/27/2009 | US20090215812 Biomarkers for evaluating likelihood of tumor sensitivity to an mtor inhibitor |
| 08/27/2009 | US20090215800 Enzyme and Receptor Modulation |
| 08/27/2009 | US20090215765 Neuroprotective compounds for treating optic neuropathies |
| 08/27/2009 | US20090215761 Quinobenzoxazine analogs and methods of using thereof |
| 08/27/2009 | US20090215720 Polysaccharides Compositions Comprising Fucans and Galactans and their Use to Reduce Extravasation and Inflammation |
| 08/27/2009 | US20090215711 Novel compositions and methods in cancer |
| 08/27/2009 | US20090215710 Carbohydrate based toll-like receptor (tlr) antagonists |
| 08/27/2009 | US20090215709 Methylation markers for diagnosis and treatment of cancers |
| 08/27/2009 | US20090215692 Compositions and methods to prevent cancer with cupredoxins |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215689 Fgf2-binding peptides and uses thereof |
| 08/27/2009 | US20090215686 Nk1-based polypeptides and related methods |
| 08/27/2009 | US20090215679 Disease-associated proteins |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090215671 Compositions And Methods For Treatment of Neural Disorders Using Transforming Growth Factor-Beta Superfamily Proteins And Their Antagonists |
| 08/27/2009 | US20090215666 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 08/27/2009 | US20090215640 Methods for identifying ligands for stem cells and cells derived therefrom |
| 08/27/2009 | US20090215177 Methods, surface modified plates and compositions for cell attachment, cultivation and detachment |
| 08/27/2009 | US20090215176 Differential Pressure Pump System |
| 08/27/2009 | US20090215175 Modulation of the poliovirus receptor function |
| 08/27/2009 | US20090215174 Methods of inhibiting umami taste receptors |
| 08/27/2009 | US20090215173 PKD Ligands and Polynucleotides Encoding PKD Ligands |
| 08/27/2009 | US20090215172 Methods and Compositions Related to Cyclic Peptide Synthesis |
| 08/27/2009 | US20090215171 PELCAM-1-related molecules compositions kit of parts and associated methods of use |
| 08/27/2009 | US20090215170 Plexin family-like polypeptide, DNA encoding the same and uses thereof |
| 08/27/2009 | US20090215169 Method for regulating protein function in cells using synthetic small molecules |
| 08/27/2009 | US20090215148 bioconjugates of chemically reactive carbocyanine dyes that are intramolecularly crosslinked between the 1-position and the 3-position; use in analysis and separation of molecules and cells and for the detection and quantification of other materials |
| 08/27/2009 | US20090215145 Method for controlling nad(p)/nad(p)h ratio by oxidoreductase |
| 08/27/2009 | US20090215123 Method for Producing Continuous Cell Lines |
| 08/27/2009 | US20090215107 Activator for Transient Receptor Potential Vanilloid 2 Comprising Probenecids |
| 08/27/2009 | US20090215083 Selecting, culturing and creating lineage committed hematopoietic stem cells |
| 08/27/2009 | US20090215065 Diagnosis and treatment of Hereditary Spastic Paraplegia |
| 08/27/2009 | US20090215051 Novel Assay |
| 08/27/2009 | US20090215046 Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer |
| 08/27/2009 | US20090215042 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 08/27/2009 | US20090215028 Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV |
| 08/27/2009 | US20090214744 Methods for increasing stearate content in soybean oil |
| 08/27/2009 | US20090214703 Transgenic Plant Expressing Maltogenic Alpha-Amylase |
| 08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
| 08/27/2009 | US20090214632 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 08/27/2009 | US20090214627 Methods of modifying insulin signaling using biliverdin reductase |
| 08/27/2009 | US20090214626 Platinum Complexes For Targeted Drug Delivery |
| 08/27/2009 | US20090214622 Nanoporous Membrane and Method of Preparation Thereof |
| 08/27/2009 | US20090214589 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 08/27/2009 | US20090214581 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| 08/27/2009 | US20090214580 Peptide mixtures with immunomodulatory activity |
| 08/27/2009 | US20090214579 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
| 08/27/2009 | US20090214576 Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of disease |
| 08/27/2009 | US20090214574 Anti-cd16 binding molecules |
| 08/27/2009 | US20090214569 Use of HIV envelope/CD4 complexes for the generation antibodies |
| 08/27/2009 | US20090214566 Protective anti-glucan antibodies with preference for beta-1,3- glucans |
| 08/27/2009 | US20090214565 Anti-Interferon Alpha Monoclonal Antibodies and Methods For Use |
| 08/27/2009 | US20090214564 Anti-ephrinb2 antibodies and methods using same |
| 08/27/2009 | US20090214560 Binding molecules to the human ox40 receptor |
| 08/27/2009 | US20090214559 Therapeutic Human Anti-IL-1R1 Monoclonal Antibody |
| 08/27/2009 | US20090214556 Antibodies and related molecules that bind to 161p2f10b proteins |
| 08/27/2009 | US20090214553 Complete human monoclonal IgG4lambda specific for CTLA-4 and uses thereof for detection of soluble CTLA-4 and isolation of regulatory cells |
| 08/27/2009 | US20090214549 Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical Field |
| 08/27/2009 | US20090214547 Binding member towards pneumolysin |
| 08/27/2009 | US20090214543 Methods for treating cancer using an immuno-toxin comprising an exotoxin a moiety having a furin cleavage site replaced with a cancer associated protease site cleaved by mmp-2 or mmp-9 |
| 08/27/2009 | US20090214534 Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY |
| 08/27/2009 | US20090214528 Host cell lines for production of antibody constant region with enhanced effector function |
| 08/27/2009 | US20090214525 Novel anti-igf-ir antibodies and uses thereof |
| 08/27/2009 | US20090214524 Methods and compositions for regulating cell cycle checkpoints |
| 08/27/2009 | US20090214515 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 08/27/2009 | US20090214513 Mammalian expression systems |
| 08/27/2009 | US20090214510 Broad Spectrum Antiviral Compositions |
| 08/27/2009 | US20090214508 Vegf-activated fas ligands |
| 08/27/2009 | US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue |
| 08/27/2009 | US20090214495 Vascular endothelial growth factor-d (vegf)-d and functionally fragments thereof for bone repairing |
| 08/27/2009 | US20090214494 Cancer Vaccines and Therapeutic Methods |
| 08/27/2009 | US20090214493 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells |
| 08/27/2009 | US20090214492 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 08/27/2009 | US20090214491 Method Of Using Mitotically Inactivated Stem Cells For Damaged Tissue Repair |
| 08/27/2009 | US20090214490 Human embryonic stem cell methods and podxl expression |
| 08/27/2009 | US20090214489 Peptides and compounds that bind to a receptor |
| 08/27/2009 | US20090214483 Progenitor Cells and Uses Thereof |
| 08/27/2009 | US20090214482 Transgenic Mammals Expressing Human Preproinsulin |
| 08/27/2009 | US20090214481 Treatment of ischemia using stem cells |
| 08/27/2009 | US20090214480 Novel cancer antigen peptide and the use thereof |
| 08/27/2009 | US20090214465 Quinoxaline Derivatives as Antitumor Agents |
| 08/27/2009 | US20090214439 Fluorinated Carbohydrates and Their Use in Tumor Visualization, Tissue Engineering, and Cancer Chemotherapy |
| 08/27/2009 | US20090214435 Recombinant vector expressing MDR1 shRNA and thymidine kinase and use thereof |
| 08/27/2009 | US20090214428 Human Monoclonal Antibodies Against Hendra and Nipah Viruses |
| 08/27/2009 | US20090214427 Novel peptides |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/27/2009 | US20090214421 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 08/27/2009 | CA2752838A1 Cell processing and/or enrichment methods |
| 08/27/2009 | CA2716343A1 Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof |
| 08/27/2009 | CA2716183A1 Means for improving agrobiological traits in a plant by providing a plant cell comprising in its chloroplasts enzymatic activities for converting glycolate into malate |